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Identification of a family of human F-box proteins
C. Cenciarelli*†, D.S. Chiaur*†, D. Guardavaccaro*, W. Parks‡, M. Vidal§
and M. Pagano*
F-box proteins are an expanding family of eukaryotic
proteins characterized by an approximately 40 amino-
acid motif, the F box (so named because cyclin F was
one of the first proteins in which this motif was
identified) [1]. Some F-box proteins have been shown to
be critical for the controlled degradation of cellular
regulatory proteins [2,3]. In fact, F-box proteins are one
of the four subunits of ubiquitin protein ligases called
SCFs. The other three subunits are the Skp1 protein;
one of the cullin proteins (Cul1 in metazoans and Cdc53
or Cul A in the yeast Saccharomyces cerevisiae); and
the recently identified Roc1 protein (also called Rbx1 or
Hrt1). SCF ligases bring ubiquitin conjugating enzymes
(either Ubc3 or Ubc4) to substrates that are specifically
recruited by the different F-box proteins. The need for
high substrate specificity and the large number of
known F-box proteins in yeast and worms [2,4] suggest
the existence of a large family of mammalian F-box
proteins. Using Skp1 as a bait in a yeast two-hybrid
screen and by searching DNA databases, we identified a
family of 26 human F-box proteins, 25 of which were
novel. Some of these proteins contained WD-40
domains or leucine-rich repeats; others contained either
different protein–protein interaction modules or no
recognizable motifs. We have named the F-box proteins
that contain WD-40 domains Fbws, those containing
leucine-rich repeats Fbls, and the remaining ones Fbxs.
We have further characterized representative members
of these three classes of F-box proteins.
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Results and discussion
We used an improved version of the yeast two-hybrid
system [5] and human Skp1 as bait to search for novel
human F-box proteins. The MaV103 yeast strain harbor-
ing a fusion between the Gal4 DNA-binding domain and
Skp1 was transformed with an activated T-cell cDNA
library expressed as fusion proteins with the Gal4 activa-
tion domain. After the initial selection and re-transforma-
tion steps, three different reporter assays were used to
select 13 clones that specifically interacted with human
Skp1. After sequence analysis, the 13 rescued cDNAs were
found to be derived from seven different open reading
frames, all encoding F-box proteins, six of which were
novel (Figure 1). One of these, β-Trcp, was also identified
by others while our screen was in progress [6]. To identify
additional human members of this family, we searched
various databases using the amino-acid sequences corre-
sponding to the conserved residues of the F-box motif of
human F-box proteins. This analysis revealed the pres-
ence of human expressed sequence tags (ESTs) encoding
nineteen additional, as yet unidentified, human F-box
proteins (Figure 1a).
Computer analysis of the newly identified human F-box
proteins revealed several interesting features (Figure 1b).
Three F-box proteins contained WD-40 domains; seven
contained leucine-rich repeats, and six contained other
potential protein–protein interaction modules not yet
identified in F-box proteins, such as leucine zippers, ring
fingers, helix-loop-helix domains, proline-rich motifs and
Src homology 2 (SH2) domains. Outside these domains,
human F-box proteins, like those of other organisms,
shared very limited homology.
A partially overlapping group of vertebrate F-box proteins
has been identified by the laboratories of W. Harper and
S. Elledge (mammalian F-box proteins) [7] and
P. Jackson (Xenopus F-box proteins) [8]. To avoid future
confusion over nomenclature, we have agreed on a consis-
tent naming and numbering scheme for this very large
family of proteins. Three subdivisions have been created
within the F-box protein family that recognize the addi-
tional motifs in the protein sequences. Thus, we have
named the F-box proteins that contain WD-40 domains
Fbws, those containing leucine-rich repeats Fbls, and the
remaining ones Fbxs. All other previously identified
human F-box proteins — β-Trcp (Fbw1a), β-Trcp2
(Fbw1b), Skp2 (Fbl1) and cyclin F (Fbx1) — are the first
members of the respective three classes; the other
members have been numbered in the order of their dis-
covery. A compilation of mammalian F-box sequences
from this paper and Winston et al. [7] is shown in the Sup-
plementary material of the latter paper.
As representative examples of all three classes of F-box pro-
teins, we characterized the full-length members (Figure 2
and Supplementary material). We determined whether
Fbw2, Fbl3a, Fbx4 and Fbx7, like Fbw1a/β-Trcp and
Fbl1/Skp2, interact with human Skp1 and Cul1 in vivo.
FLAG epitope-tagged versions of wild-type Fbw1a/β-Trcp,
Fbw2, Fbl3a, Fbx4 and Fbx7, and mutant versions of
Fbw1a, Fbw2 and Fbl3a lacking the F box (∆F), were
expressed in HeLa cells, and the cell extracts subjected to
immunoprecipitation with an anti-FLAG antibody. As
detected in immunoblots, F-box proteins coprecipitated
with Cul1 and Skp1, but not with Cul2 (another human
cullin), and only using extracts from cells expressing wild-
type F-box proteins (Figure 2a and data not shown). 
The binding of F-box proteins to the Skp1–Cul1 complex
is consistent with the possibility that F-box proteins associ-
ate with a ubiquitin ligation activity. To test this possibility,
we expressed FLAG-tagged F-box proteins together with
human Skp1 and Cul1 in HeLa cells. Cell extracts were
subjected to immunoprecipitation with an anti-FLAG anti-
body and assayed for ubiquitin ligase activity in the pres-
ence of the human ubiquitin-activating enzyme (E1) and a
human Ubc. All of the wild-type F-box proteins tested, but
not F-box protein mutants, associated with a ubiquitin
ligase activity that produced a high molecular weight smear
characteristic of ubiquitinated proteins (Figure 2b). The
ligase activity was sensitive to N-ethylmaleimide (NEM;
lane 2) and required the presence of both Ubc4 and E1
(data not shown). Results similar to those with Ubc4 were
obtained using human Ubc3 (data not shown), whereas
Ubc2 was unable to sustain the ubiquitin ligase activity of
these SCFs (Figure 2b, lanes 12,13 and data not shown).
This is the first demonstration that, in addition to Fbws and
Fbls, Fbxs can associate with a ubiquitin ligase activity.
In humans, two SCF complexes have been identified and
characterized, one of which contains Fbw1a/β-Trcp and
the other Fbl1/Skp2. We and others have recently shown
that SCFFbl1/Skp2 is required for ubiquitination of the
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Figure 1
The family of human F-box proteins and its
three classes, Fbw, Fbl and Fbx. A single
dagger denotes F-box proteins identified
through a two-hybrid screen; a double
dagger denotes those identified by database
searching. (a) Alignment of the F boxes of 
F-box proteins identified through a two-hybrid
screen or BLAST searches and those of the
four previously known F-box proteins
(Fbw1a/β-Trcp, Fbw1b/β-Trcp2, Fbl1/Skp2
and Fbx1/cyclin F). The alignment was
performed using the Clustal W method
(MacVector) followed by manual re-
adjustment. An asterisk indicates the
presence of a stop codon; sequences
without asterisks are incomplete at the 3′
end. Dark grey, identical residues in at least
13 F boxes; light grey, residues that are
similar. The consensus sequence is indicated
below; capital letters indicate identical
residues and lower case letters indicate
similar residues. The cDNA sequences
corresponding to the F-box proteins reported
in this figure have been deposited in the
GenBank database (accession numbers
AF129530–AF129537 and
AF174589–AF174606). (b) Schematic
representation of the human F-box proteins
containing putative protein–protein
interaction domains. Double slashes, cDNAs
that were incomplete at the 5′ end; asterisks,
stop codons. 
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cyclin-dependent kinase inhibitor p27Kip1, both in vivo
[9,10] and in vitro [9,11] and that SCFFbw1a/βTrcp recruits
β-catenin and IκBα for ubiquitin-mediated degradation
[12,13]. Degradation of many other mammalian cellular reg-
ulatory proteins (for example, cyclins, c-Myc, c-Jun, E2F
and p300) is controlled by the ubiquitin pathway [14]. Yet,
the specific enzymes involved in the degradation of these
regulatory proteins are not known. This description of a
large family of human F-box proteins will allow a better
understanding of the role and the specificity of SCF com-
plexes in the regulation of ubiquitin-mediated proteolysis.
Supplementary material
Supplementary material including additional methodological details and
three figures showing specific interaction of F-box proteins with Skp1
through the F box, subcellular localization of F-box proteins, expression
in human tissues and a compilation of F-box sequences from this paper
and [7] is available at http://current-biology.com/supmat/supmatin.htm.
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Figure 2
All three classes of human F-box proteins
associate with a ubiquitin ligase activity in
vivo. (a) HeLa cells were transfected with
plasmids encoding FLAG-tagged versions of
Fbw1a/β-Trcp (lane 1), (∆F)Fbw1a (lane 2),
Fbx4 (lane 3), Fbx7 (lane 5), Fbw2 (lane 7),
(∆F)Fbw2 (lane 8), Fbl3a (lane 9), (∆F)Fbl3a
(lane 10), or with empty vector (lanes 4,6).
Cells were lysed and extracts subjected to
immunoprecipitation (IP) with a rabbit anti-
FLAG antibody (lanes 1–10). Immuno-
precipitates were then immunoblotted with
an anti-FLAG antibody (to detect F-box
proteins) or antibodies against the indicated
proteins. Lane 11, 10 ng purified
recombinant Cul1, Skp1 and Cul2 proteins
used as markers; lane 12, lysate from non-
transfected HeLa cells (25 µg protein).
(b) HeLa cells were transfected with
plasmids encoding human Skp1, Cul1 and
FLAG-tagged versions of Fbw1a/β-Trcp
(lane 3), (∆F)Fbw1a (lane 4), Fbw2
(lanes 2,5), (∆F)Fbw2 (lane 6), Fbx7 (lane 7),
Fbl3a (lanes 8,13), (∆F)Fbl3a (lane 9), an
irrelevant FLAG-tagged protein
(Irf3, lane 10), Fbx4 (lanes 11,12) or with an
empty vector (lane 1). Cells were lysed and
extracts were immunoprecipitated with a
rabbit anti-FLAG antibody.
Immunoprecipitates were incubated in the
presence of purified recombinant E1 and
Ubc4 (lanes 1–11) or Ubc2 (lanes 12,13)
and biotinylated ubiquitin. The reaction in
lane 2 also contained NEM. Ubiquitinated
proteins were visualized by blotting with
horseradish peroxidase (HRP)-conjugated
streptavidin. The bracket on the left
highlights the smear of ubiquitinated proteins
produced in the reaction, the asterisk
indicates ubiquitin conjugated with E1 that
was resistant to boiling. 
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Supplementary materials and methods
Plasmid construction for the yeast two-hybrid system
The pPC97-CYH2 and the pPC86 plasmids [S1,S2] contain LEU2
and TRP1 as selectable markers and encode, respectively, the DNA-
binding domain (DB, amino acids 1–147) and the transcriptional acti-
vation domain (AD, amino acids 768–881) of yeast Gal4. The
in-frame DB fusion with full-length human Skp1 was obtained by
homologous recombination of the PCR product amplified with the fol-
lowing two oligonucleotides: 5′ primer, 5′-AGTAGTAACAAAGGT-
CAAAGACAGTTGACTGTATCGTCGAGGATGCCTTCAATTAAGTT-
3′; 3′ primer, 5′-GCGGTTACTTACTTAGAGCTCGACGTCTTACT-
TACTTAGCTCACTTCTCTTCACACCA-3′. The 5′ primer corresponds
to a DB sequence present in the pPC97-CYH2 plasmid (italicized)
flanked by the 5′ sequence of the SKP1 gene. The 3′ primer corre-
sponds to a sequence within the polylinker of the pPC97-CYH2
plasmid (italicized) flanked by the 3′ sequence of the SKP1 gene. The
PCR product (100 ng) was transformed into yeast cells (MaV103 strain
[S1,S2]) with or without 100 ng pPC97-CYH2 plasmid previously
restricted with SalI and BglII. As a result of the homologous recombina-
tion, only yeast cells containing the pPC97-CYH2 plasmid homologously
recombined with SKP1 cDNA grew efficiently in the absence of leucine. 
Library screen for Skp1 interactors and cloning of full-length
F-box proteins
MaV103 strain [S1] harboring the DB–Skp1 fusion was transformed
with an activated T-cell cDNA library (Alala 2, [S3]) cloned in pPC86.
Transformation was performed using the standard lithium acetate
method. Approximately 3 × 106 yeast transformants were first plated
onto synthetic complete plates lacking both leucine and tryptophan (Sc-
Leu-Trp) and incubated for 60 h. The resulting transformants were
replica-plated onto Sc-Leu-Trp plates containing 20 mM 3-aminotriazole
(3-AT). Growing yeast colonies were picked after an additional four-day
Supplementary material
Figure S1
F-box proteins interact specifically with Skp1 through their F box. The
various wild-type and mutant F-box protein cDNAs were transcribed
and translated in vitro in the presence of [35S]methionine. Similar
amounts of in vitro translated proteins (indicated at the top of each
lane) were subjected to a His tag pull-down assay using
nickel–agarose beads to which similar amounts of either His-tagged
Skp1 (lanes 1,3,4,6–10,13,15,17,19,21), His-tagged elongin C
(lanes 2,5,11,14,16,18,20,22), or His-tagged p27 (lane 12) were pre-
bound. Human elongin C, which is related to Skp1, was used as a
negative control. Immunoblotting with an antibody against the His tag
showed that similar amounts of His-tagged proteins were used (data
not shown). Bound in vitro translated proteins were analyzed by
SDS–PAGE and autoradiography. The arrows on the left point to the
indicated F-box proteins. The apparent molecular weights of the
protein standards are indicated on the right.
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Figure S2
Expression of transcripts encoding F-box proteins in human tissues.
Membranes containing electrophoretically fractionated poly(A)+ mRNA
from different human tissues were hybridized with specific probes
prepared from FBW1a/β-TRCP, FBW2, FBL3a, FBX4, FBL1/SKP2 and
β-ACTIN cDNAs. The arrows on the left point to the major transcripts.
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incubation and further tested in the MaV103 ‘three reporter assays’: first,
growth on Sc-Leu-Trp plates supplemented with 20 mM 3-AT to assay
for GAL1::HIS3; second, expression of β-galactosidase activity to assay
for GAL1::lacZ; and third, no growth on Sc-Leu-Trp plates supple-
mented with 0.2% 5-fluoro-orotic acid to assay for SPAL10::URA3. The
corresponding AD plasmids were transformed back into cells expressing
either the DB–Skp1 bait fusion or DB alone as a negative control. Thir-
teen AD plasmids that repeatedly tested positive in at least two reporter
assays were rescued in Escherichia coli and sequenced. Two of the
clones encoding Fbx4 and Fbx5 appeared to be full length; full-length
clones of four other cDNAs encoding Fbw1a/β-Trcp, Fbw2, Fbl3a and
Fbx7 were obtained by rapid amplification of cDNA ends (RACE) using
Marathon-Ready cDNA libraries (Clontech) according to the manufactur-
er’s instructions. A full-length clone encoding Fbx6 was not obtained.
Criteria for full-length clones included at least two of the following: identi-
fication of an open reading frame (ORF) yielding a sequence related to
known F-box proteins; presence of a consensus Kozak translation initia-
tion sequence at a putative initiator methionine codon; identification of a
stop codon in the same reading frame but upstream of the putative initia-
tion codon; inability to further increase the size of the clone by RACE
using three different cDNA libraries. Note that all the F-box proteins
obtained with the two-hybrid screen (Fbw1a/β-Trcp, Fbw2, Fbl3a, Fbx4,
Fbx5, Fbx6 and Fbx7) were used as negative controls in experiments
published very recently in [S4]. In that study, they were indicated as
Fbp1, Fbp2, Fbp3a, Fbp4, Fbp5, Fbp6 and Fbp7, respectively.
DNA database searches and analysis of protein motifs
The National Center for Biotechnology Information and The Institute for
Genomic Research which encompass the major database of ESTs were
searched for sequences with homology to F-box protein genes by using
BLAST, PSI-BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) and TGI
Sequence Search (http://www.tigr.org/cgi-bin/BlastSearch/blast_tgi.cgi).
ESTs that overlapped more than 95% in at least 100 bp were
assembled into novel contiguous ORFs using Sequencher 3.0.
Protein domains were identified using the ProfileScan Server
(http://www.isrec.isb-sib.ch/software/PFSCAN_form.html), BLOCKS
Searcher (http://www.blocks.fhcrc.org/blocks_search.html) and IMB
Jena (http://genome.imb-jena.de/cgi-bin/GDEWWW/menu.cgi). 
Accession numbers
The 26 sequences reported in this paper have been deposited in the
GenBank database (accession numbers AF129530–AF129537 and
AF174589–AF174606). 
Construction of F-box mutants
(∆F)Fbw1a (residues 32–179), (∆F)Fbw2 (residues 60–101), (∆F)Fbl3a
(residues 40–76), (∆F)Fbx4 (residues 55–98) were obtained by deletion
with the appropriate restriction enzymes with conservation of the reading
frame. Fbl3a mutants in which the Leu51 residue was mutated to Ala
(L51A), or the Trp76 residue mutated to Ala (W76A) were generated by
oligonucleotide-directed mutagenesis using the polymerase chain reac-
tion of the QuikChange site-directed mutagenesis kit (Stratagene). All
mutants were sequenced in their entirety.
Recombinant proteins
The cDNA fragments encoding the entire coding region of human
Skp1, and Elongin C with a hexahistidine (His) tag at the amino termi-
nus were inserted into the baculovirus expression vector pBacpak-8
(Clontech) and cotransfected into Sf9 cells with linearized baculovirus
DNA using the BaculoGold transfection kit (Pharmingen). Recombinant
viruses were used to infect 5B cells and assayed for expression of their
encoded protein by immunoblotting as described [S5]. His-tagged pro-
teins were purified with Nickel–agarose (Invitrogen) according to the
manufacturer’s instructions. 
Northern blot analysis
Northern blots were performed using human multiple-tissue mRNAs
from Clontech. Probes were radiolabeled with [α-32P]dCTP (Amer-
sham) using a random primer DNA labeling kit (Gibco BRL;
2 × 106 cpm/ml). Washes were performed with 0.2 × SSC, 0.1% SDS,
at 55–60°C. FBW1a/β-TRCP and FBL3a probes were two HindIII
restriction fragments (nucleotides 1–571 and 1–450, respectively),
FBW2, FBX4 and FBL1/SKP2 probes were their respective full-length
cDNAs, and the β-ACTIN probe was from Clontech. 
Antibodies, transient transfections, immunoprecipitation and
immunoblotting 
Polyclonal antibodies to Cul1, Cul2 and Skp1, as well as mouse mono-
clonal antibodies to Cul1, were generated and characterized as
described [S6]. Mouse anti-FLAG antibody was from Kodak, mouse
anti-histidine antibody from Clontech and rabbit anti-FLAG antibody from
Zymed. The cDNAs encoding the human proteins Fbw1a, (∆F)Fbw1a,
Fbw2, (∆F)Fbw2, Fbl3a, (∆F)Fbl3a, Fbl3a(L51A), Fbl3a(W76A), Fbx4,
(∆F)Fbx4 were inserted into the mammalian expression vector pcDNA3
(Invitrogen) in frame with sequences encoding a FLAG tag at the 5′
end. Cells were transfected with FuGENE transfection reagent
(Boehringer) according to the manufacturer’s instructions. Conditions
for protein extraction, immunoblotting, and immunoprecipitation have
been previously described [S4,S5]. 
Ubiquitination assay 
Immuno-beads containing SCF complexes immunoprecipitated with an
anti-FLAG antibody were added together with purified recombinant
human E1 and Ubc enzymes (Ubc2, Ubc3 or Ubc4) to a reaction mix
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Figure S3
Subcellular localization of F-box proteins.
HeLa cells were transfected with mammalian
expression plasmids encoding FLAG-tagged
versions of (a,b) Fbw1a/β-Trcp, (c,d) Fbw2,
(e,f) Fbl3a, (g,h) Fbx4, (i,j) (∆F)Fbw2, or
(k,l) (∆F)Fbl3a. After 24 h, (a,c,e,g,i,k) F-box
proteins were stained with a rabbit anti-FLAG
antibody and (b,d,f,h,j,l) DNA with
bisbenzimide. Fbw1a/β-Trcp and Fbx4 were
found distributed both in the cytoplasm and in
the nucleus, Fbw2 was detected mainly in the
cytoplasm and Fbl3a mainly in the nucleus.
The identical localization of wild-type and
mutant F-box proteins demonstrates that the
presence of the F box and the F-box-
dependent binding to Skp1 do not determine
the subcellular localization of F-box proteins.
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containing biotinylated ubiquitin. Samples were then analyzed by
immunoblotting with HRP–streptavidin. E1, Ubc enzymes and biotiny-
lated ubiquitin were produced as described [S7]. Polyubiquitinated
species generated in this assay may be formed by cellular substrates
that co-immunoprecipitated with the ligase, as proposed for similar
experiments performed with Fbl1/Skp2 [S8]; or unanchored ubiquitin
polymers as proposed in [S9]; or auto-ubiquitinated components of the
Ubc–SCF complex.
Immunofluorescence
Transfected cell monolayers growing on glass coverslips were rinsed
in PBS and fixed with 4% paraformaldehyde in PBS for 10 min at 4°C
followed by permeabilization for 10 min with 0.25% Triton X-100 in
PBS. Other fixation protocols gave comparable results. Immunofluo-
rescence stainings were performed using 1 µg/ml rabbit anti-FLAG
antibody as described [S10]. 
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